What does client service mean to us? It means developing custom relationships, sharing our technical expertise, and providing practical solutions delivered by pragmatic IP professionals who are easy to work with. We carefully structure our teams to ensure that we have the right blend of knowledge and experience to meet the unique needs of each client. Regardless of the industry in which you operate, our patent, design and trade mark specialists will quickly understand your business and your IP issues, with the addition of significant value right from the start of the working relationship.
EXPERTISE
"They are a very bright, thoughtful bunch and are easy to work with. Their advice is timely, comprehensive, commercial and very sound."
Client quote, Chambers and PartnersWe are a people business. To deliver exceptional service to our clients, we seek individuals with a combination of talent, commercial awareness, and integrity. Our clients depend on our expertise – but they also appreciate our individual personalities and our collaborative way of working. Within a supportive working environment, we empower our staff to strive for excellence. We recognise that when our employees reach their full potential, our firm also succeeds.
CAREERSFrom 9 July 2026, Algeria's accession to the Hague Apostille Convention will simplify document attestation for IP matters between member countries, replacing multi-stage legalisation with Apostille.
Swatch's US$170m claim against Samsung could reshape UK trade mark damages by recognising the commercial value of brand reputation, exclusivity and goodwill in the digital economy.
The EASYBREATH and Elvie decisions show how technical function can limit design protection and why evidence of aesthetic design choices remains crucial.
Boult once again ranked for both trade mark prosecution and patent prosecution (patent & trade mark attorney firms) by Managing IP IP Stars.
Boult’s guide to IP rights and exclusivity for pharma and biotech in Europe.
Discover how patent protection plays a fundamental role in incentivising and rewarding research and development in the pharmaceutical and biotechnology sectors.
TRENDING TOPICS
